Search Results 2011-2020 of 19594 for hemoglobin

1. Publications - Mark J. Spangehl, M.D. - Mayo Clinic

   Routine Postoperative Hemoglobin and Hematocrit Tests Are Unnecessary Following Primary Total Hip and Knee Arthroplasty. Arthroplast Today. 2024 Dec; 30 ...

2. Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) - Mayo Clinic

   Hemoglobin ≥ 9 g/dL; Platelets ≥ 100,000 mm^3 or ≥ 100 × 10^9/L. Have adequate hepatic function as evidenced by: Serum total bilirubin ≤1.5 × upper limit ...

3. A Study to Evaluate T-DM1 With or Without Abemaciclib in Women and Men with HER2-positive Advanced or Metastatic Breast Cancer - Mayo Clinic

   Hemoglobin ≥ 9.0 g/dL (obtained ≤ 14 days prior to randomization). Creatinine ≤ 1.5 X upper limit of normal (ULN) (obtained ≤ 14 days prior to ...

4. Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations - Mayo Clinic

   - Hemoglobin >= 9.0 g/dL with no blood transfusion in the past 28 days (obtained =< 7 days prior to registration) - Total bilirubin =< 1.5 x upper limit of ...

5. Clinical trials - Oncology (Medical)

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

6. Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma - Mayo Clinic

   Hematological: Absolute neutrophil count (ANC) ≥1500/μL, Platelets ≥100,000/μL; Hemoglobin ≥9.0 g/dL or ≥5.6 mmol/L;; Renal: Estimated glomerular ...

7. A Study to Evaluate Niraparib and TSR-042 in Patients with Germline or Somatic BRCA1/2 and PALB2-related Pancreatic Cancer - Mayo Clinic

   Hemoglobin ≥9.0 g/dL;; Absolute neutrophil count ≥1500/μL;; Platelets ≥100x109/L;; Total bilirubin ≤1.5 x ULN, (2.0 x ULN for subjects with Gilbert's ...

8. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

   NOTE: Labs must also be obtained within 10 days prior to C1D1 treatment. * Absolute Neutrophil Count (ANC) ≥ 1,100/mm3 * Hemoglobin (Hgb) ≥ 8.5 g/dL without ...

9. A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme - Mayo Clinic

   ... hemoglobin ≥ 10 g/dL; 2. Hepatic function: bilirubin ≤ 1.5 × × the upper limit of normal (ULN) (excluding. Gilberts Syndrome, for which bilirubin must be ...

10. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

    Hemoglobin ≥ 9 g/dL;; Serum total bilirubin ≤ 1.5× upper limit of normal (ULN) (total bilirubin must be < 3 × ULN for patients with documented Gilbert's ...